Intellipharmaceutics International Inc. announced the resignation of Shameze Rampertab, Vice President, Finance and Chief Financial Officer, who is leaving the company effective October 10, 2014 to pursue an opportunity in the medical devices industry. Pending the hiring of a replacement for Mr. Rampertab, the functions of Chief Financial Officer for Intellipharmaceutics will be carried out by the Company's President and former Chief Financial Officer, Dr. Amina Odidi.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% | -11.11% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 19.33L | |
+55.95% | 82TCr | |
-6.98% | 35TCr | |
+19.08% | 33TCr | |
+9.05% | 30TCr | |
+17.34% | 24TCr | |
+2.25% | 23TCr | |
+13.28% | 22TCr | |
+8.91% | 17TCr | |
-3.44% | 16TCr |
- Stock Market
- Equities
- IPCI.H Stock
- News Intellipharmaceutics International Inc.
- IntelliPharmaCeutics International Inc. Announces Executive Changes